← Eichor
Study identifier: NCT06444269 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial

Condition: Breast Cancer  ·  Sponsor: University of Texas Southwestern Medical Center

PhasePhase 2
Planned participants53
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

1\. Efficacy of PULSAR preoperative radiation 2. Evaluate potential of microbubble CEUS as an alternative to operative SLNBx 3. Evaluate potential of OA to evaluate treatment response of pre-operative radiation on the tumor

This description comes directly from the study's public registry record.

Talk to the study team

Sarah Neufeld, MS  ·  214-645-8525  ·  sarah.hardee@utsouthwestern.edu

Basak Dogan, MD  ·  214/645-3290  ·  Dogan.Basak@utsouthwestern.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UT Southwestern Medical Center-DallasDallas, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06444269